In vitro mass production of reproducible human cells destined for substitution therapy: Challenges for development of functional materials for what we need most in transfusion!

In this concise section of TRASCI What ’s Happening I am pleased to offer readers five mini-reports reflecting on mass production of transfusable human cultured cells destined for substitution therapy. Special thanks are due to my contributors for helping me to bring together this concise theme which highlights supportive studies for i mplementation of culturing blood cells with a focus on advances in cultured RBC [CRBC]. Also, I am, in particular, grateful to Prof. Jason Acker for reviewing my personal contributions to this theme.

Source: Transfusion and Apheresis Science - June 28, 2020 Category: Hematology Authors: Jerard Seghatchian Tags: Editorial Source Type: research